Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer

Abstract

ER- or PR-negative subgroup showed worse prognosis than ER- and PR-positive subgroup in the luminal B HER2-negative group. We could consider the negativity of ER or PR as prognostic marker in luminal B HER2-negative subtype of breast cancer.